Clinical Trials Sponsored by Alertgy

Total 3433 results

The Cleveland Clinic
Alertgy

Completed

Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM)

Type 2 Diabetes

United States
Allergy Therapeutics

Completed

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Seasonal Allergic Rhinitis | Rhinoconjunctivitis

United States, Germany, Austria, Hungary, Czechia, Poland
Allergy Therapeutics

Withdrawn

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Type I Hypersensitivity

Canada
HAL Allergy

Completed

Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Canada
HAL Allergy

Completed

HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human

Rhinitis, Allergic | Rhinoconjunctivitis, Allergic

Canada
HAL Allergy

Completed

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

Belgium, Germany, Czech Republic, Poland, Slovakia
HAL Allergy

Completed

SUBLIVAC FIX Mite Mixture Dose Tolerability Study (DTS)

House Dust Mite Allergy

Germany
HAL Allergy

Completed

SUBLIVAC FIX Phleum Pratense DT/DRF

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany, Poland
HAL Allergy

Completed

PURETHAL Grasses Rush Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

United States
Allergy Therapeutics

Recruiting

Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects (PROTECT)

Peanut Allergy

United States
Allergy Therapeutics

Completed

An Exploratory Study of PQ Grass 27600 SU

Rhinitis, Allergic, Seasonal

United States, Germany
Allergy Therapeutics

Completed

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Type I Hypersensitivity

United States
Allergy Therapeutics

Completed

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics

Terminated

Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
HAL Allergy

Completed

HAL-MPE1 First-in-human (HAL-MPE1/0043)

Peanut Allergy

Denmark
HAL Allergy

Completed

SUBLIVAC® Birch PROBE Study

Birch Pollen Allergy | Seasonal Rhinitis and/or Rhinoconjunctivitis

Germany
HAL Allergy

Completed

Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany
Allergy Therapeutics

Completed

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Type I Hypersensitivity

Germany
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Ragweed MATA MPL

Type I Hypersensitivity

Canada, United States
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Type I Hypersensitivity

United States
Allergy Therapeutics

Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

Respiratory Tract Infections | Allergy | Rhinitis, Allergic | Allergic Conjunctivitis | Allergic Asthma

Germany
HAL Allergy

Completed

HAL-MPE1 Safety and Tolerability Study

Peanut Allergy

United States, Canada
HAL Allergy

Completed

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Belgium, Germany, Austria, Netherlands, Spain
HAL Allergy

Completed

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland, Czech Republic, Germany
HAL Allergy

Completed

Twin SUBLIVAC® Grasses Clinical Efficacy Study

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Germany, Poland, Belgium, Netherlands
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Grass MATA MPL

Type I Hypersensitivity

United States, Canada, United Kingdom, Austria
Allergy Therapeutics

Completed

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Type I Hypersensitivity

United States
HAL Allergy
Ergomed

Completed

PURETHAL Birch RUSH Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland
United Allergy Services

Unknown

Microassay and Allergy Skin Prick Test Correlation Study

Allergy Pollen

United States
United Allergy Services

Unknown

Corn Occupational Rhinitis SCIT Efficacy Study

Rhinitis
United Allergy Services

Completed

The Efficacy & Safety of the UAS Immunotherapy Protocol

Perennial Allergic Rhinitis With Seasonal Variation

United States
Nambudripad's Allergy Research Foundation

Completed

NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar

Hyperglycemia | Hypoglycemia | Fatigue | Allergy | Indigestion

United States
Nambudripad's Allergy Research Foundation

Completed

Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).

Milk Allergy

United States
Nambudripad's Allergy Research Foundation

Completed

Importance of Hand Washing After Each NAET® Treatment

Allergy

United States
Food Allergy Research & Education

Recruiting

A Registry for the Food Allergy Community (FPR)

Food Hypersensitivity | Eosinophilic Esophagitis | Anaphylaxis | Food Intolerance | Food Sensitivity | Food Allergy in Infants

United States
Food Allergy Support Team

Completed

Registry of Food Allergy Oral Immunotherapy Treatment

Food Allergy

United States
McMaster University
Hamilton Allergy

Completed

Eczema Reminder and Accountability Program (ERAP)

Eczema | Atopic Dermatitis

Canada
Nambudripad's Allergy Research Foundation

Completed

An Autism Study Using Nambudripad's Food Allergy Elimination Treatments

Autism | Food Allergies

United States
Nambudripad's Allergy Research Foundation

Completed

NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®

Headache | Indigestion | Food Sensitivities | Backache | Eczema, Acne, Hives and Itching of the Skin

United States
National Allergy Research Center, Denmark

Recruiting

Contact Allergy to Rubber Accelerators - a Clinical Study

Contact Allergy

Denmark
National Allergy Research Center, Denmark

Not yet recruiting

Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool

Allergic Contact Dermatitis

Clinical Trials Sponsored by Alertgy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations